Jasper Therapeutics's total assets for Q1 2025 were $57.60M, a decrease of -27.91% from the previous quarter. JSPR total liabilities were $15.35M for the fiscal quarter, a -15.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.